JEA’s former headquarters in downtown is closer to being renovated into a mixed-use residential property after the city-owned utility’s board voted Tuesday to sell it to a Jacksonville-based developer ...

JSW Motors has taken a bold step towards announcing its entry into India’s passenger vehicle space, placing a full front-page advertisement ...

Plug-in hybrids are starting to find favour – and for good reason, given their inherent practicality, with more than a hint ...

Reported positive update from Phase 2 CRDF-004 trial in first-line RAS-mutated mCRC, with the 30 mg onvansertib + FOLFIRI/bev arm demonstrating: ...

Children with multiple nut allergies experienced significant increases in the amounts of allergens they could tolerate with ...

Espresso and other coffees can perk you up and have health benefits, but too much caffeine may cause side effects.

Eli Lilly and Company (NYSE: LLY) announced on February 23, 2026, that the U.S. Food and Drug Administration has approved a ...

The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.

Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) - 20 mg cohort demonstrated rapid and robust fetal hemoglobin (HbF ...

Eli Lilly has rolled out a multi-dose KwikPen version of tirzepatide, marketed as Zepbound, for chronic weight management—signaling a packaging update for one of the obesity market’s fastest-expanding ...

Novo Nordisk's shares fell over 14% following the disappointing results of its CagriSema drug trial against Eli Lilly's ...